Opioids Agonist Drugs Market Trends, Business Overview, Industry Growth and
Forecast to 2031

The global opioids agonist drugs market is anticipated to
grow at a significant CAGR during the forecast period (2024-2031). The major
factors that are fuelling the growth of the market include the growing
prevalence of pain and diarrhea. Opioids are generally used for treating pain,
however, opioid-containing drugs are being misused or are being consumed in
overdose when patients follow self-medication. The opioid drug class comprises
morphine, hydrocodone, oxycodone, heroin, codeine, morphine, fentanyl, and
methadone. It is also employed as a cough suppressant and in diarrhea
treatment. Opioids can be administered either through pills, liquids,
intravenous, transdermal patches, or lozenges. Developed nations in North
America and Europe have high levels of abuse of this drug. Drugs such as
codeine, morphine, fentanyl, and hydrocodone have become a source of addiction,
especially among the population, owing to the easy availability of drugs in
these regions. 

Get Free Sample link @ https://www.omrglobal.com/request-sample/opioids-agonist-drugs-market

However, global organisations as well as regulatory agencies
including the FDA, Centers for Disease Control and Prevention (CDC), and World
Health Organization (WHO) are working towards restricting the abuse of opioids
by creating awareness and educating prescribers to be cautious while
prescribing these drugs. In 2016, the CDC issued guidelines to prescribe
opioids, limiting the daily dose of opioids to 90 morphine milligram equivalent
(MME). In recent years, cannabis has emerged as an alternative for opioids.
Cannabis is legalized in many states in the US, as it is considered safer than
opioids. Therefore, legalizing cannabis (marijuana) is a factor that is
expected to have a detrimental impact on the market growth during the forecast
period. 

Full report of Opioids Agonist Drugs Market available @
https://www.omrglobal.com/industry-reports/opioids-agonist-drugs-market

Market Coverage

• Segment
  Covered


• Regions
  Covered- Globally

Competitive Landscape: Pfizer Inc., Boehringer
Ingelheim GmbH, and Sanofi S.A., among others. 

Key questions addressed by the report

• What
  is the market growth rate?


• Which
  segment and region dominates the market in base year?


• Which
  segment and region will project fastest growth in the market?


• How
  COVID-19 impacted the market?

o             Recovery
Timeline

o             Deviation
from pre-COVID forecast

o             Most
affected region and segment

• Who
  is the leader in the market?


• How
  players are addressing challenges to sustain growth?


• Where
  is the investment opportunity?

Global Opioids Agonist Drugs Market Report by Segment

By Product 

•                
Codeine

•                
Fentanyl

•                
Meperidine

•                
Methadone

•                
Others

By Application 

•                
Pain Management 

•                
Cough Treatment

•                
Diarrhea Treatment

Reasons to Buying From us -



1. We cover more than 15 major industries, further segmented into more than 90
sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after
purchasing your report.

For
More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/opioids-agonist-drugs-market

Media Contact:



Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research



About Orion Market Research



Orion Market Research (OMR) is a market research and consulting company known
for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services. The company also offers Digital Marketing services through its
subsidiary OMR Digital and Software development and Consulting Services through
another subsidiary Encanto Technologies.